Nephron Pharmaceuticals partners with New York company ahead of product expansion

Listen to this article

Nephron Pharmaceuticals Corp. and New York-based Sharps Technology have formed a new partnership focused on developing and sharing best practices in manufacturing, product development and quality as Nephron prepares to launch its InjectEZ expansion.

“Sharps Technology has identified a unique opportunity to collaborate with a leader in the industry like Nephron,” Robert Hayes, CEO of Sharps Technology, said in a news release. “Through my previous industry experience supporting and working with most of the leading healthcare and pharmaceutical companies in the world, it was easy for me to evaluate Nephron as a potential partner.”

Sharps Technology is a medical device and pharmaceutical packaging company specializing in drug delivery systems. Nephron Pharmaceuticals produces and manufactures generic inhalation solutions and pre-filled, sterile syringes through its 503B Outsourcing Facility. 

The company’s new InjectEZ project will enable Nephron to manufacture its own syringes, rubber stoppers and plungers.

“We are excited to kick off a partnership with Sharps Technology as our InjectEZ expansion project opens,” said Nephron CEO Lou Kennedy. “Just as the InjectEZ syringe manufacturing facility is poised to play a critical role in assisting those we work with on tackling emerging public health crises, Sharps Technology also offers key solutions to healthcare challenges.”

Sharps will also work with Nephron to develop a pharmaceuticals service program to support health care customers that need solutions and products to support their business, according to the release.

Related content:

Nephron Nitrile welcomes first shipment of equipment

InnoVision Awards to recognize this Columbia CEO for achievement

Female executives: Business acumen fostered at early age

Manufacturing takes center stage at Nephron Nitrile